Disease Areas
Diabetes
Obesity
Cardiovascular Disease (CVD)
Chronic Kidney Disease (CKD)
Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Neurodegenerative Diseases
Haemophilia
Sickle Cell Disease
Primary Hyperoxaluria
Growth Hormone Disorders
Hormone Replacement Therapy
Congresses
Scientific Publications
IME
Search Science Hub
Register
Login
My Account
Welcome to Novo Nordisk Science Hub
Are you a healthcare professional?
No
Yes
Congresses
EASD 2025
Control of eating with semaglutide 7.2 mg in adults with obesity: The STEP UP trial
EASD 2025
EASD 2025
15 - 19 September 2025
Control of eating with semaglutide 7.2 mg in adults with obesity: The STEP UP trial
Sorry! It looks like the page you are trying to access contains materials that are still under embargo. Please come back and check again later.
Share
Copy link
{{pageUrl}}
Keywords
Obesity
Congress oral presentation
GLP-1 RA
Semaglutide
PHASE 3 (RCT)
Get notified when materials for EASD 2025 and future congresses become available:
Slide decks
Posters
Videos ... and more.
Get notified when materials for EASD 2025 and future congresses become available:
Slide decks
Posters
Videos ... and more.
{{ error.$message }}
Success
We will notify you when new materials become available for EASD 2025 and future congresses.
We will keep you updated in your inbox:
Subscribe to receive updates on related congresses in the same disease area:
Almost Done